Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.
Screening for pathogenic mutations in breast and ovarian cancer genes such as BRCA1/2, CHEK2 and RAD51C is common practice for individuals from high-risk families. However, test results may be ambiguous due to the presence of unclassified variants (UCV) in the concurrent absence of clearly cancer-pr...
Main Authors: | Barbara Wappenschmidt, Alexandra A Becker, Jan Hauke, Ute Weber, Stefanie Engert, Juliane Köhler, Karin Kast, Norbert Arnold, Kerstin Rhiem, Eric Hahnen, Alfons Meindl, Rita K Schmutzler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3519833?pdf=render |
Similar Items
-
A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
by: Ridout, C, et al.
Published: (2008) -
Mutations primarily alter the inclusion of alternatively spliced exons
by: Pablo Baeza-Centurion, et al.
Published: (2020-10-01) -
Functional analysis of splicing mutations in exon 7 of <it>NF1 </it>gene
by: Calvieri Stefano, et al.
Published: (2007-02-01) -
Effect of <it>BRCA2 </it>sequence variants predicted to disrupt exonic splice enhancers on <it>BRCA2 </it>transcripts
by: Brewster Brooke L, et al.
Published: (2010-05-01) -
An exonic splicing enhancer mutation in DUOX2 causes aberrant alternative splicing and severe congenital hypothyroidism in Bama pigs
by: Chunwei Cao, et al.
Published: (2019-01-01)